Simpson Thacher Attorneys Author Law360 Article on Ninth Circuit Dismissal of Securities Fraud Class Action
Litigation Partners Stephen Blake, Meredith Karp and Jonathan Youngwood authored an article, “9th Circ. Ruling May Help Pharma Cos. Avert Investor Claims,” which was published by Law360. The article discussed a recent Ninth Circuit decision affirming the dismissal of a securities fraud class action against a pharmaceutical company and its executives for allegedly misleading investors through deceptive marketing materials. It also offered key takeaways for pharmaceutical companies looking to avoid potential securities fraud claims related to their slogans intended for healthcare investors.
To read the full article, please click here (subscription required).